# The Efficacy and Safety of Tenofovir Amibufenamide to Treat Low-level Viraemia After Entecavir Treatment

> **NCT05755776** · — · UNKNOWN · sponsor: **The Second Affiliated Hospital of Chongqing Medical University** · enrollment: 204 (estimated)

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **DRUG:** TMF

## Key facts

- **NCT ID:** NCT05755776
- **Lead sponsor:** The Second Affiliated Hospital of Chongqing Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-03-01
- **Primary completion:** 2024-12
- **Final completion:** 2024-12
- **Target enrollment:** 204 (ESTIMATED)
- **Last updated:** 2023-09-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05755776

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05755776, "The Efficacy and Safety of Tenofovir Amibufenamide to Treat Low-level Viraemia After Entecavir Treatment". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05755776. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*